Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM
在儿童急性淋巴细胞白血病（ALL）患者中，基于白消安或曲奥舒凡的预处理方案进行异基因造血干细胞移植（allo-HSCT）后，疗效相当：FORUM 研究结果
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024014548
Kalwak, Krzysztof; Moser, Laura M; Pötschger, Ulrike; Bader, Peter; Kleinschmidt, Katharina; Meisel, Roland; Dalle, Jean-Hugues; Yesilipek, Akif; Balduzzi, Adriana; Krivan, Gergely; Goussetis, Evgenios; Staciuk, Raquel; Sedlacek, Petr; Pichler, Herbert; Svec, Peter; Gabriel, Melissa; Güngör, Tayfun; Bilic, Ernest; Buechner, Jochen; Renard, Marleen; Vettenranta, Kim; Ifversen, Marianne; Diaz-de-Heredia, Cristina; Stein, Jerry; Toporski, Jacek; Bierings, Marc; Peters, Christina; Ansari, Marc; Locatelli, Franco
